Acasti Pharma reported $-938K in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Acasti Pharma USD -938K 2.42M Sep/2025
Addus HomeCare USD 25.07M 4.71M Mar/2026
Amarin USD -1.22M 6.51M Dec/2025
Cassava Sciences USD -10.33M 2.21M Mar/2026
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Option Care Health USD 58.5M 6.69M Dec/2025
Organigram Holdings CAD -921K 20.89M Mar/2026
Tilray USD -44.93M 44.61M Sep/2025